Does Bimzelx Treat Scalp Psoriasis?
Bimzelx (bimekizumab-bkzx) is FDA-approved for moderate to severe plaque psoriasis in adults, including specific approval for psoriasis affecting the scalp. Clinical trials showed it clears scalp psoriasis effectively, with 65-72% of patients achieving complete clearance (ss-0 score) after 16 weeks, compared to 5-10% on placebo.[1][2]
How Effective Is Bimzelx for Scalp Symptoms?
In phase 3 trials (BE RADIANT and BE READY), Bimzelx reduced scalp-specific Physician Global Assessment (PGA) scores rapidly. By week 4, over 50% of patients had minimal or no scalp psoriasis, rising to 78-84% with clear or almost clear scalps by week 16. It targets IL-17A and IL-17F cytokines, which drive scalp inflammation more aggressively than on other body areas.[1][3]
How Does Bimzelx Compare to Other Psoriasis Drugs for Scalp?
Bimzelx outperforms IL-17 inhibitors like Cosentyx (secukinumab) in head-to-head trials for scalp clearance: 72% vs. 51% at week 16. Against IL-23 inhibitors like Tremfya (guselkumab), it shows similar or better scalp results (65% vs. 56%). Unlike topicals, it treats scalp psoriasis systemically without messy application.[2][4]
| Drug | Scalp Clearance Rate (Week 16) |
|------|-------------------------------|
| Bimzelx | 65-72% [1] |
| Cosentyx | 51% [4] |
| Tremfya | 56% [2] |
| Skyrizi | 53% [5] |
What Do Real Patients Report for Scalp Psoriasis?
Patient forums and reviews note Bimzelx clears thick scalp plaques within weeks, often reducing itching and flaking faster than prior biologics. Some report 90-100% improvement, though a minority experience initial shedding before clearance. It's injected every 4 weeks initially, then every 8-12 weeks.[6]
Are There Limitations or Risks for Scalp Use?
Bimzelx works for most plaque psoriasis on the scalp but lacks data for pustular or erythrodermic types. Common side effects include upper respiratory infections (15-20%) and oral candidiasis (7-14%), with rare risks of IBD flares. Not studied in pregnancy; monitor for infections.[1][7] No scalp-specific safety issues beyond general psoriasis trials.
When Can You Expect Scalp Improvement?
Visible scalp relief starts by week 2-4, with peak clearance by week 16. Maintenance dosing sustains results in 80-90% of responders.[1]
Sources
[1]: FDA Bimzelx Label
[2]: Gordon KB et al., Lancet 2021 (BE RADIANT trial)
[3]: Reich K et al., NEJM 2021 (BE READY trial)
[4]: Warren RB et al., Lancet 2022 (head-to-head vs. Cosentyx)
[5]: Reich K et al., Lancet 2017 (Tremfya scalp data)
[6]: Patient reviews aggregated from Drugs.com and Psoriasis.org forums
[7]: Bimzelx prescribing information, UCB Pharma